Periodic Reporting for period 1 - PB_LC (Clinical readiness of a live biotherapeutic for treatment of Non-Small Cell Lung Cancer (NSCLC))

Lung cancer (LC) is a major disease burden, standing as the second most diagnosed cancer and the leading cause of cancer-related deaths worldwide. In 2020, LC accounted for 2.2 million new cases and 1.8 million deaths globally, making up 11.4% of all cancer diagnoses and a...